The Role of Tyrosine Kinase in Ca^(2+)-Independent Contraction of the Ropivacaine on Rat Aortic Smooth Muscle

10.4077/CJP.2013.BAC214

Zhen Lei；Jian-Bo Wu；Tao Meng；Qi-Yu Bo；Xin-Yu Zhang；Jing-Ya Yu；Jing-Ui Yu

aorta ； muscle ； ropivacaine ； smooth ； tyrosine kinase

The Chinese Journal of Physiology

56卷6期（2013 / 12 / 31）

349 - 356

英文

The tyrosine kinase signaling pathway plays an important role in the mediation of Ca^(2+) independent mechanisms of smooth muscle contraction. Several components of this pathway, including protein kinase C (PKC), p44/42 mitogen-activated protein kinase (p44/42 MAPK) and Rho-kinase are involved in Ca^(2+) independent mechanisms. Whether the tyrosine kinase pathway mediates vasoconstriction induced by the anesthetic ropivacaine remains unclear. The present study was designed to examine the role of tyrosine kinase in ropivacaine-induced, Ca^(2+)-independent contraction of rat aortic smooth muscle. The effects of tyrosine kinase inhibitor on ropivacaine-induced contractile response were observed by isometric force measurement. The protein tyrosine phosphorylation, PKC, p44/42 MAPK, and membrane translocation of Rho-kinase were examined by Western blotting. Ropivacaine induced a concentration-dependent contractile response, and showed a number of effects on protein tyrosine phosphorylation. In this study, phosphorylation levels were shown to increase at lower concentrations of ropivacaine, but the levels decline at higher concentrations in rat aortic rings attenuated by the tyrosine kinase inhibitor genistein in a concentration-dependent fashion. Ropivacaine-induced phosphorylation of PKC and p44/42 MAPK and Rho-kinase membrane translocation were also significantly attenuated by genistein in similar decreasing manner as the PKC inhibitor bisindolylmaleimide I (Bis I) and the Rho-kinase inhibitor, Y27632, but to a lesser degree than that by the p44/42 MAPK inhibitor, PD 098059. Our results showed that the ropivacaine-induced, Ca^(2+) independent-mediated contraction of rat aortic smooth muscle is, in part, regulated by tyrosine kinase-catalyzed protein tyrosine phosphorylation.

1. Su, X.L.,Zhang, H.,Yu, W.,Wang, S.,Zhu, W.J.(2013).Role of KCa3.1 channels in proliferation and migration of vascular smooth muscle cells by diabetic rat serum.Chinese J. Physiol.,56,155-162.
   連結：
2. Tang, W.B.,Zhou, Y.Q.,Zhao, T.,Shan, J.L.,Sun, P.,Yang, T.T.,Chang, X.W.,Li, S.,Wang, P.S.,Xie, D.P.(2011).Effect of interleukin-6 (IL-6) on the vascular smooth muscle contraction in abdominal aorta of rats with streptozotocin-induced diabetes.Chinese J. Physiol.,54,318-323.
   連結：
3. Wang, W.,Jiang, D.,Zhu, Y.,Liu, W.,Duan, J.,Dai, S.(2009).Relaxing effects of phytoestrogen alphazearalanol on rat thoracic aorta rings in vitro.Chinese J. Physiol.,52,99-105.
   連結：
4. Yang, A.L.,Lo, C.W.,Lee, J.T.,Su, C.T.(2011).Enhancement of vasorelaxation in hypertension following high-intensity exercise.Chinese J. Physiol.,54,87-95.
   連結：
5. Akiyama, T.,Ishida, J.,Nakagawa, S.,Ogawara, H.,Watanabe, S.,Itoh, N.(1987).Genistein, a specific inhibitor of tyrosine-specific protein kinases.J. Biol. Chem.,25,5592-5595.
6. Briggs, S.D.,Bryant, S.S.,Jove, R.,Sanderson, S.D.,Smithgall, T.E.(1995).The Ras GTPase-activating protein (GAP) is an SH3 domain-binding protein and substrate for the Src-related tyrosine kinase, Hck.J. Biol. Chem.,270,14718-14724.
7. Choi, B.H.,Park, J.H.,Hahn, S.J.(2006).Open channel block of Kv3.1 currents by genistein, a tyrosine kinase inhibitor.Korean J. Physiol. Pharmacol.,10,71-77.
8. Cristina Castañeda-Patlán, M.,Razo-Paredes, R.,Carrisoza-Gaytán, R.,González-Mariscal, L.,Robles-Flores, M.(2010).Protein kinase C is involved in the regulation of several calreticulin posttranslational modifications.Int. J. Biochem. Cell Biol.,42,120-131.
9. Di Salvo, J.,Nelson, S.R.,Kaplan, N.(1997).Protein tyrosine phosphorylation in smooth muscle: a potential coupling mechanism between receptor activation and intracellular calcium.Proc. Soc. Exp. Biol. Med.,214,285-301.
10. Dojo, M.,Kinoshita, H.,Nakahata, K.,Kimoto, Y.,Hatano, Y.(2004).Effects of bupivacaine enantiomers and ropivacaine on vasorelaxation mediated by adenosine triphosphate-sensitive K+ channels in the rat aorta.Anesthesiology,101,251-254.
11. Eguchi, S.,Matsumoto, T.,Motley, E.D.,Utsunomiya, H.,Inagami, T.(1996).Identification of an essential signaling cascade for mitogen-activated protein kinase activation by angiotensin II in cultured rat vascular smooth muscle cells. Possible requirement of Gq-mediated p21ras activation coupled to a Ca2+/calmodulin-sensitive tyrosine kinase.J. Biol. Chem.,271,14169-14175.
12. Ellis, C.,Moran, M.,McCormick, F.,Pawson, T.(1990).Phosphorylation of GAP and GAP-associated proteins by transforming and mitogenic tyrosine kinases.Nature,343,377-381.
13. Fukata, Y.,Amano, M.,Kaibuchi, K.(2001).Rho-Rho-kinase pathway in smooth muscle contraction and cytoskeletal reorgnization of non-muscle cells.Trends Pharmacol. Sci.,22,32-39.
14. Gherardini, G.,Samuelson, U.,Jernbeck, J.,Aberg, B.,Sjöstrand, N.(1995).Comparison of vascular effects of ropivacaine and lidocaine on isolated rings of human arteries.Acta. Anaesthesiol. Scand.,39,765-768.
15. Govêia, C.S.,Magalhães, E.(2010).Ropivacaine in peribulbar anesthesia-vasoconstrictive properties.Rev. Bras. Anestesiol.,60,495-512.
16. Harnett, K.M.,Biancani, P.(2003).Calcium-dependent and calcium-independent contractions in smooth muscles.Am. J. Med.,115,24-30.
17. Hyun, D.J.,Uy, D.S.(2009).Inhibitory effect of genistein on agonist-induced modulation of vascular contractility.Mol. Cell,27,191-198.
18. Ishihata, A.,Tasaki, K.,Katano, Y.(2002).Involvement of p44/42 mitogen-activated protein kinases in regulating angiotensin II- and endothelin-1-induced contraction of rat thoracic aorta.Eur. J. Pharmacol.,445,247-256.
19. Ishiyama, T.,Dohi, S.,Iida, H.,Watanabe, Y.(1997).The effects of topical and intravenous ropivacaine on canine pial microcirculation.Anesth. Analg.,85,75-81.
20. Kaplan, N.,Di Salvo, J.(1996).Coupling between [arginine8]-vaso-pressin-activated increases in protein tyrosine phosphorylation and cellular calcium in A7r5 aortic smooth muscle cells.Arch. Biochem. Biophys.,326,271-280.
21. Kopacz, D.J.,Carpenter, R.L.,Mackey, D.C.(1989).Effect of ropivacaine on cutaneous capillary blood flow in pigs.Anesthesiology,71,69-74.
22. Kuiper, G.G.,Lemmen, J.G.,Carlsson, B.,Corton, J.C.,Safe, S.H.,Van der Saag, P.T.,Van der Burg, B.,Gustafsson, J.A.(1998).Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor.Endocrinology,139,4252-4263.
23. Li, H.F.,Zhang, P.,Tian, Z.F.,Qiu, X.Q.,Zhang, Y.F.,Wu, J.X.,Jia, Z.J.(2006).Differential mechanisms involved in effects of genistein and 17-beta-estradiol on porcine coronary arteries.Pharmazie,61,461-465.
24. Marrero, M.B.,Schieffer, B.,Paxton, W.G.,Schieffer, E.,Bernstein, K.E.(1995).Electroporation of pp60c-src antibodies inhibits the angiotensin II activation of phospholipase c-gamma 1 in rat aortic smooth muscle cells.J. Biol. Chem.,270,15734-15738.
25. Martins, C.A.,Aragão, P.W.,Freire, S.M.,Martins, M.M.,Borges, M.O.,Borges, A.C.(2005).Effect of ropivacaine on neuronal norepinephrine reuptake in smooth muscle.Rev. Bras. Anestesiol.,55,532-537.
26. Meisenhelder, J.,Suh, P.,Rhee, S.G.,Hunter, T.(1989).Phospholipase C is a substrate for the PDGF and EGF receptor protein-tyrosine kinases in vivo and in vitro.Cell,57,1109-1120.
27. Molloy, C.J.,Taylor, D.S.,Weber, H.(1993).Angiotensin II stimulation of rapid protein tyrosine phosphorylation and protein kinase activation in aortic smooth muscle cells.J. Biol. Chem.,268,7338-7345.
28. Murphy, T.V.,Spurrell, B.E.,Hill, M.A.(2002).Cellular signalling in arteriolar myogenic constriction: involvement of tyrosine phosphorylation pathways.Clin. Exp. Pharmacol. Physiol.,29,612-619.
29. Smith, P.K.,Krohn, R.I.,Hermanson, G.T.,Mallia, A.K.,Gartner, F.H.,Provenzano, M.D.,Fujimoto, E.K.,Goeke, N.M.,Olson, B.J.,Klenk, D.C.(1985).Measurement of protein using bicinchoninic acid.Anal. Biochem.,150,76-85.
30. Somlyo, A.P.,Somlyo, A.V.(2003).Ca2+ sensitivity of smooth muscle and non muscle myosin II: modulated by G proteins, kinases, and myosin phosphatase.Physiol. Rev.,83,1325-1358.
31. Sung, H.J.,Sohn, J.T.,Park, J.Y.,Hwang, E.M.,Baik, J.S.,Ogawa, K.(2009).Direct effect of ropivacaine involves lipoxygenase pathway activation in rat aortic smooth muscle.Can. J. Anaesth.,56,298-306.
32. Takahashi, E.,Berk, B.C.(1998).MAP kinases and vascular smooth muscle function.Acta. Physiol. Scand.,164,611-621.
33. Wahl, M.I.,Olashaw, N.E.,Nishibe, S.,Rhee, S.G.,Pledger, W.J.,Carpenter, G.(1989).Platelet-derived growth factor induces rapid and sustained tyrosine phosphorylation of phospholipase C in quiescent BALB/c 3T3 cells.Mol. Cell Biol.,9,2934-2943.
34. Walsh, M.P.,Horowitz, A.,Clement-Chomienne, O.,Andrea, J.E.,Allen, B.G.,Morgan, K.G.(1996).Protein kinase C mediation of Ca2+-sensitivity contractions of vascular smooth muscle.Biochem. Cell Biol.,74,485-502.
35. Ward, D.T.,Alder, A.C.,Ohanian, J.,Ohanian, V.(2002).Noradrena-line-induced paxillin phosphorylation, ERK activation and MEK-regulated contraction in intact rat mesenteric arteries.J. Vasc. Res.,39,1-11.
36. Williams, J.K.,Clarkson, T.B.(1998).Dietary soy isoflavones inhibit in-vivo constrictor responses of coronary arteries to collagen-induced platelet activation.Coron Artery Dis.,9,759-764.
37. Yu, J.,Ogawa, K.,Tokinaga, Y.,Hatano, Y.(2003).S evoflurane inhibits GTPÉ◊S-stimulated, Rho/Rho-kinase-mediated contraction of isolated rat aortic smooth muscle.Anesthesiology,99,646-651.
38. Yu, J.,Tokinaga, Y.,Kuriyama, T.,Uematsu, N.,Mizumoto, K.,Hatano, Y.(2005).The involvement of Ca2+ sensitization in ropivacaine-induced contraction of rat aortic smooth muscle.Anesthesiology,103,548-555.
39. Yu, J.,Tokinaga, Y.,Ogawa, K.,Iwahashi, S.,Hatano, Y.(2004).Sevoflurane inhibits angiotensin II-induced, protein kinase C-mediated but not Ca2+-elicited contraction of rat aortic smooth muscle.Anesthesiology,100,879-884.
40. Zhan, G.,Lau, C.P.,Wong, T.M.,Li, G.R.(2004).Protein tyrosine kinase-dependent modulation of voltage-dependent potassium channels by genistein in rat cardiac ventricular myocytes.Cell. Signal.,16,333-341.